TY - JOUR
T1 - Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions
AU - Brockmann, Eeva Christine
AU - Cooper, Matthew
AU - Strömsten, Nelli
AU - Vehniäinen, Markus
AU - Saviranta, Petri
N1 - Funding Information:
We thank Medix Biochemica (Kauniainen, Finland) for providing genetic material for the 5404 antibody. Déborah Braun is thanked for help with panning. The study was financially supported by the National Technology Agency of Finland (TEKES).
PY - 2005/1
Y1 - 2005/1
N2 - Stability of single-chain Fvs (scFvs) can be improved by mutagenesis followed by phage display selection where the unstable variants are first inactivated by, for example, denaturing treatment. Here we describe a modified strategy for the selection of stabilized antibody fragments by phage display, based on denaturation under reducing conditions. This strategy was applied to an anti-thyroid-stimulating hormone (TSH) scFv fragment which refolded remarkably during the selection if denaturation was carried out in conventionally used non-reducing conditions. Refolding was, however, efficiently prevented by combining denaturation with reduction of the intra-domain disulfide bridges, which created favourable conditions for selection of clones with improved stability. Using this strategy, scFv mutants with 8-9°C improved thermal stability and 0.8-0.9 M improved stability for guanidinium chloride were found after 4-5 enrichment cycles. The most stable mutants selected contained either LysH66Arg or AsnH52aSer mutations, which are known to stabilize other scFvs. Periplasmic expression level of the mutants was also improved.
AB - Stability of single-chain Fvs (scFvs) can be improved by mutagenesis followed by phage display selection where the unstable variants are first inactivated by, for example, denaturing treatment. Here we describe a modified strategy for the selection of stabilized antibody fragments by phage display, based on denaturation under reducing conditions. This strategy was applied to an anti-thyroid-stimulating hormone (TSH) scFv fragment which refolded remarkably during the selection if denaturation was carried out in conventionally used non-reducing conditions. Refolding was, however, efficiently prevented by combining denaturation with reduction of the intra-domain disulfide bridges, which created favourable conditions for selection of clones with improved stability. Using this strategy, scFv mutants with 8-9°C improved thermal stability and 0.8-0.9 M improved stability for guanidinium chloride were found after 4-5 enrichment cycles. The most stable mutants selected contained either LysH66Arg or AsnH52aSer mutations, which are known to stabilize other scFvs. Periplasmic expression level of the mutants was also improved.
KW - Antibody engineering
KW - Disulfide bond
KW - Phage display
KW - Protein denaturation
KW - Protein stability
UR - http://www.scopus.com/inward/record.url?scp=12944308809&partnerID=8YFLogxK
U2 - 10.1016/j.jim.2004.11.008
DO - 10.1016/j.jim.2004.11.008
M3 - Article
C2 - 15680160
AN - SCOPUS:12944308809
VL - 296
SP - 159
EP - 170
JO - Journal of Immunological Methods
JF - Journal of Immunological Methods
SN - 0022-1759
IS - 1-2
ER -